The sales claim matters more than the label
FDA is the Food and Drug Administration. FDA has alleged that research-labelled peptide products promoted for human use were unapproved drugs sold unlawfully. The research wording did not change FDA’s view of their intended use.
FDA has also cited mixing water and preparation tools as evidence that sellers expected human injection.
These findings come from warning letters to particular firms. A warning letter is an allegation at that time, not a court ruling.
A product code is not an approval
An NDC number is a code that identifies a drug in FDA’s list. FDA cautions that a product’s code establishes no approval.
“FDA registered” is also different from “FDA approved.” Putting a medicine maker or drug on FDA’s records does not mean FDA approved it.
Injection adds a separate concern
FDA told peptide sellers that shots can carry germs and poisonous substances past some of the body’s defences. It described the possible harm as serious.
For several proposed peptide ingredients, FDA is concerned about extra substances in the medicine that should not be there. It is also concerned that the body’s system for fighting disease may react against the injected peptide.
Ask what reactions are known for your exact product and which symptoms need urgent help.
Bring it back to a checkable care plan
Keep the label and the claim together when asking. Do not let the conversation move to a broad story about peptides before the exact product is explained.